Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Grillo, Giovanni
Zucchetti, Elisa
Inzoli, Elena
Mancini, Valentina
Forno, Barbara
Lotesoriere, Ivana
Bertani, Giambattista
Cairoli, Roberto
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5553
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of Sorafenib on the Outcomes of Patients With FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Xuan, Li
    Wang, Yu
    Huang, Fen
    Jiang, Erlie
    Deng, Lan
    Wu, Bingyi
    Fan, Zhiping
    Liang, Xinquan
    Xu, Na
    Ye, Jieyu
    Lin, Ren
    Yin, Changxin
    Zhang, Yuanyuan
    Sun, Jing
    Han, Mingzhe
    Huang, Xiaojun
    Liu, Qifa
    CANCER, 2018, 124 (09) : 1954 - 1963
  • [2] FLT3-ITD Mutation and Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Case Study
    Saeed, Shahzeb
    Nagaraj, Raghu Halappa
    Grezenko, Han
    Rehman, Abdur
    Shehryar, Abdullah
    Anwaar, Mohammad Ahsan
    Lazarevic, Slobodan
    Shahzed, S. M. Iram
    Das, Archana
    Vargas, Karla I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [3] The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Xuan, Li
    Wang, Yu
    Huang, Fen
    Wu, Bingyi
    Fan, Zhiping
    Xu, Na
    Ye, Jieyu
    Sun, Jing
    Huang, Xiaojun
    Liu, Qifa
    BLOOD, 2017, 130
  • [4] A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation
    Pratz, Keith W.
    Rudek, Michelle A.
    Smith, B. Douglas
    Karp, Judith
    Gojo, Ivana
    Dezern, Amy
    Jones, Richard J.
    Greer, Jackie
    Gocke, Christopher
    Baer, Maria R.
    Duong, Vu H.
    Rosner, Gary
    Zahurak, Marianna
    Wright, John J.
    Emadi, Ashkan
    Levis, Mark
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 300 - 306
  • [5] Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia
    Canaani, Jonathan
    Labopin, Myriam
    Huang, Xiao Jun
    Arcese, William
    Ciceri, Fabio
    Blaise, Didier
    Irrera, Giuseppe
    Corral, Lucia Lopez
    Bruno, Benedetto
    Santarone, Stella
    van Lint, Maria Teresa
    Vitek, Antonin
    Esteve, Jordi
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2017, 130
  • [6] Prognostic Impact of Immunophenotyping for Normal Karyotype Acute Myeloid Leukemia in the Absence of FLT3-ITD Mutation
    Jiang, A.
    Jiang, H.
    Xu, W.
    Brandwein, J.
    Kamel-Reid, S.
    Chang, H.
    MODERN PATHOLOGY, 2010, 23 : 305A - 305A
  • [7] Prognostic Impact of Immunophenotyping for Normal Karyotype Acute Myeloid Leukemia in the Absence of FLT3-ITD Mutation
    Jiang, A.
    Jiang, H.
    Xu, W.
    Brandwein, J.
    Kamel-Reid, S.
    Chang, H.
    LABORATORY INVESTIGATION, 2010, 90 : 305A - 305A
  • [8] Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation
    Iannotta, R.
    Celentano, M.
    Marotta, S.
    Pedata, C. M.
    Riccardi, C.
    Migliaccio, I.
    Viola, A.
    Muggianu, S. M.
    Falco, C.
    Bovenzi, D.
    Ferrara, F.
    Picardi, A.
    LEUKEMIA RESEARCH REPORTS, 2022, 18
  • [9] Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation
    Jentzsch, Madlen
    Bischof, Lara
    Brauer, Dominic
    Backhaus, Donata
    Ussmann, Jule
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Platzbecker, Uwe
    Schwind, Sebastian
    CANCERS, 2023, 15 (04)
  • [10] FLT3-ITD Incidence and FLT-D835 Mutations in Acute Myeloid Leukemia Patients with Normal Karyotype in Morocco: A Preliminary Study
    Dehbi, Hind
    Kassogue, Yaya
    Nasserddine, Sanaa
    Quessar, Asma
    Nadifi, Sellama
    MIDDLE EAST JOURNAL OF CANCER, 2013, 4 (01) : 1 - 5
12345